|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.00 EUR | +1.52% |
|
-.--% | - |
| 07-15 | Bayer, RAGT Enter Licensing Deal to Launch Hybrid Wheat Seeds | MT |
| 07-14 | ORIC Pharmaceuticals Starts Phase 3 Trial of Rinzimetostat in Metastatic Prostate Cancer | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BAYN Stock
- BAYN Stock
- Charts Bayer AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
